These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9033029)

  • 1. The lipophosphoglycan-like molecules of virulent and avirulent E. histolytica as well as of E. dispar differ in both composition and abundance.
    Moody S; Becker S; Nuchamowitz Y; McConville MJ; Mirelman D
    Arch Med Res; 1997; 28 Spec No():98-102. PubMed ID: 9033029
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of significant variation in the composition of lipophosphoglycan-like molecules of E. histolytica and E. dispar.
    Moody S; Becker S; Nuchamowitz Y; Mirelman D
    J Eukaryot Microbiol; 1998; 45(2):9S-12S. PubMed ID: 9561777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of surface glycoconjugates on Entamoeba histolytica and Entamoeba dispar.
    Pacheco-Yépez J; Campos-Rodríguez R; Rojas-Hernández S; Serrano-Luna JJ; Rivera-Aguilar V; Villa-Treviño S; Martínez-Palomo A; Tsutsumi V; Shibayama M
    Parasitol Int; 2009 Jun; 58(2):171-7. PubMed ID: 19269346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of lipophosphoglycan-like glycoconjugates in Entamoeba dispar.
    Bhattacharya A; Arya R; Clark CG; Ackers JP
    Parasitology; 2000 Jan; 120 ( Pt 1)():31-5. PubMed ID: 10726263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virulent and avirulent Entamoeba histolytica and E. dispar differ in their cell surface phosphorylated glycolipids.
    Moody S; Becker S; Nuchamowitz Y; Mirelman D
    Parasitology; 1997 Feb; 114 ( Pt 2)():95-104. PubMed ID: 9051918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipophosphoglycan is present in distinctly different form in different Entamoeba histolytica strains and absent in Entamoeba moshkovskii and Entamoeba invadens.
    Srivastava G; Anand MT; Bhattacharya S; Bhattacharya A
    J Eukaryot Microbiol; 1995; 42(5):617-22. PubMed ID: 7581337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Royal Society of Tropical Medicine and Hygiene Meeting at Manson House, London, 19 February 1998. Amoebic disease. Entamoeba histolytica and E. dispar: comparison of molecules considered important for host tissue destruction.
    Tannich E
    Trans R Soc Trop Med Hyg; 1998; 92(6):593-6. PubMed ID: 10326098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenicity of Entamoeba histolytica is related to the capacity of evading innate immunity.
    Campos-Rodríguezp R; Jarillo-Luna A
    Parasite Immunol; 2005; 27(1-2):1-8. PubMed ID: 15813717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenicity of Entamoeba dispar under xenic and monoxenic cultivation compared to a virulent E. histolytica.
    Costa AO; Gomes MA; Rocha OA; Silva EF
    Rev Inst Med Trop Sao Paulo; 2006; 48(5):245-50. PubMed ID: 17086310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pore-forming peptides of Entamoeba dispar. Similarity and divergence to amoebapores in structure, expression and activity.
    Nickel R; Ott C; Dandekar T; Leippe M
    Eur J Biochem; 1999 Nov; 265(3):1002-7. PubMed ID: 10518795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphometric study of the hepatic lesions experimentally induced in hamsters by Entamoeba dispar and E. histolytica.
    Costa CA; Brito KN; Gomes MA; Caliari MV
    Parasite; 2007 Dec; 14(4):329-34. PubMed ID: 18225422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Entamoeba dispar contains but does not secrete acid phosphatase as does Entamoeba histolytica.
    Talamás-Rohana P; Aguirre-García MM; Anaya-Ruiz M; Rosales-Encina JL
    Exp Parasitol; 1999 Jul; 92(3):219-22. PubMed ID: 10403764
    [No Abstract]   [Full Text] [Related]  

  • 13. Entamoeba dispar: ultrastructure, surface properties and cytopathic effect.
    Espinosa-Cantellano M; Gonzáles-Robles A; Chávez B; Castañ ón G; Argüello C; Lázaro-Haller A; Martínez-Palomo A
    J Eukaryot Microbiol; 1998; 45(3):265-72. PubMed ID: 9669863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entamoeba histolytica and/or Entamoeba dispar: infection frequency in HIV+/AIDS patients in Mexico city.
    Moran P; Ramos F; Ramiro M; Curiel O; González E; Valadez A; Gómez A; García G; Melendro EI; Ximénez C
    Exp Parasitol; 2005 Jul; 110(3):331-4. PubMed ID: 15955334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in morphology of phagosomes and kinetics of acidification and degradation in phagosomes between the pathogenic Entamoeba histolytica and the non-pathogenic Entamoeba dispar.
    Mitra BN; Yasuda T; Kobayashi S; Saito-Nakano Y; Nozaki T
    Cell Motil Cytoskeleton; 2005 Oct; 62(2):84-99. PubMed ID: 16106449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entamoeba histolytica: mechanism of decrease of virulence of axenic cultures maintained for prolonged periods.
    Olivos A; Ramos E; Nequiz M; Barba C; Tello E; Castañón G; González A; Martínez RD; Montfort I; Pérez-Tamayo R
    Exp Parasitol; 2005 Jul; 110(3):309-12. PubMed ID: 15955329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Entamoeba histolytica and Entamoeba dispar: differentiation methods and implications].
    Anane S; Khaled S
    Ann Biol Clin (Paris); 2005; 63(1):7-13. PubMed ID: 15689308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenic protozoans in man: differential characterization of Entamoeba histolytica/Entamoeba dispar complex, Acanthamoeba spp., Microsporidia].
    Scaglia M; Gatti S; Bruno A; Bernuzzi AM; Cevini C; Maserati R
    Parassitologia; 2001 Dec; 43 Suppl 1():37-43. PubMed ID: 12078476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional upregulation of genes related to virulence activation in Entamoeba histolytica.
    Balderas-Renteria I; García-Lázaro JF; Carranza-Rosales P; Morales-Ramos LH; Galan-Wong LJ; Muñoz-Espinosa LE
    Arch Med Res; 2007 May; 38(4):372-9. PubMed ID: 17416282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of the redefinition of the agent of amoebiasis.
    Lucas R; Upcroft JA
    Rev Latinoam Microbiol; 2001; 43(4):183-7. PubMed ID: 17061507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.